COVID‐19 hospitalization and mortality in community‐dwelling racially and ethnically diverse persons living with dementia

Community‐dwelling persons living with dementia (PLWD) are vulnerable to COVID‐19 infection, severity, and mortality due to the high prevalence of comorbidities, reliance on caregivers, and potential inability to employ risk reduction measures, among other factors.

[1]  Yu-Hui Liu,et al.  One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. , 2022, JAMA neurology.

[2]  J. Skinner,et al.  Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic. , 2022, JAMA neurology.

[3]  C. Blaum,et al.  Factors associated with hospital admission and severe outcomes for older patients with COVID‐19 , 2022, Journal of the American Geriatrics Society.

[4]  E. Moro,et al.  Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium , 2021, JAMA network open.

[5]  S. Verjovski-Almeida,et al.  Dementia is an age‐independent risk factor for severity and death in COVID‐19 inpatients , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Ice Septriani Saragih,et al.  Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study , 2021, Geriatric Nursing.

[7]  M. Gurney,et al.  COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[8]  Man-Huei Chang,et al.  COVID-19 Hospitalization by Race and Ethnicity: Association with Chronic Conditions Among Medicare Beneficiaries, January 1–September 30, 2020 , 2021, Journal of Racial and Ethnic Health Disparities.

[9]  Yuehua Wu,et al.  Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries , 2020, The Journal of infectious diseases.

[10]  Hao Li,et al.  The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis. , 2020, Journal of Alzheimer's disease : JAD.

[11]  A. Kurniawan,et al.  Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis , 2020, Archives of Gerontology and Geriatrics.

[12]  C. Cervellati,et al.  Dementia and the risk of death in elderly patients with COVID‐19 infection: Systematic review and meta‐analysis , 2020 .

[13]  C. Faes,et al.  Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients , 2020, International journal of environmental research and public health.

[14]  Eric E. Smith,et al.  Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the future , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[15]  D. Melzer,et al.  Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  B. Tousi.  Dementia Care in the Time of COVID-19 Pandemic. , 2020, Journal of Alzheimer's disease : JAD.

[17]  D. Melzer,et al.  APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort , 2020, medRxiv.

[18]  B. Pollock,et al.  Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias , 2020, The American Journal of Geriatric Psychiatry.

[19]  N. Wilson,et al.  Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality , 2020, Emerging infectious diseases.

[20]  P. Borzi,et al.  Centers for Medicare and Medicaid Services , 2020, Definitions.

[21]  Patricia Ferido,et al.  Measuring Alzheimer's Disease and Other Dementias in Diverse Populations Using Medicare Claims Data. , 2019, Journal of Alzheimer's disease : JAD.

[22]  E. Crimmins,et al.  Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data , 2019, Alzheimer's & dementia.

[23]  R. Vernooij,et al.  Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. , 2017, The Cochrane database of systematic reviews.

[24]  Greta Rait,et al.  Comorbidity and dementia: a scoping review of the literature , 2014, BMC Medicine.

[25]  D. Weaver.  Alzheimer's , 2014, Neurology.